The SARS-CoV-2 inactivated vaccine enhances the broad neutralization against variants in individuals recovered from COVID-19 up to one year

Saved in:
Bibliographic Details
Published in:Emerging microbes & infections 2022-12, Vol.11 (1), p.753-756
Main Authors: Zhou, Xinrong, Cheng, Lin, Wang, Haiyan, Liao, Xuejiao, Wang, Miao, Wei, Lanlan, Song, Shuo, Zhou, Bing, Ma, Zhenghua, Guo, Huimin, Ge, Xiangyang, Ju, Bin, Zhang, Zheng
Format: Article
Language:English
Subjects:
Antibodies, Neutralizing
Antibodies, Viral
Coronaviruses
COVID-19 - prevention & control
COVID-19 Vaccines
Humans
Letter
Neutralization Tests
SARS-CoV-2 - genetics
Spike Glycoprotein, Coronavirus - genetics
Vaccines, Inactivated
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c562t-7a5b3c9a5f493173e912f482ab714568017115345603e8d5a9dcb65ba68a43bb3
cites cdi_FETCH-LOGICAL-c562t-7a5b3c9a5f493173e912f482ab714568017115345603e8d5a9dcb65ba68a43bb3
container_end_page 756
container_issue 1
container_start_page 753
container_title Emerging microbes & infections
container_volume 11
creator Zhou, Xinrong
Cheng, Lin
Wang, Haiyan
Liao, Xuejiao
Wang, Miao
Wei, Lanlan
Song, Shuo
Zhou, Bing
Ma, Zhenghua
Guo, Huimin
Ge, Xiangyang
Ju, Bin
Zhang, Zheng
description
doi_str_mv 10.1080/22221751.2022.2043728
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_35184681</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4ca34e161c464c7a909ac6deee1603ef</doaj_id><sourcerecordid>2748035568</sourcerecordid><originalsourceid>FETCH-LOGICAL-c562t-7a5b3c9a5f493173e912f482ab714568017115345603e8d5a9dcb65ba68a43bb3</originalsourceid><addsrcrecordid>eNp9kl1rFDEUhgdRbKn9CUrAG2-mJpOPmbkRy9aPhULB1t6GM5nMbpbZpCaZlfUv-Kc9625L64UhJIeT9zwnCW9RvGb0jNGGvq9wsFqys4pWFS6C11XzrDje5cvdwfNH8VFxmtKK4qipEky8LI64ZI1QDTsuft8sLbk-_3ZdzsJtWRHnwWS3gWx7sgFjnLfE-iV4YxPJqO1igJ54O-UIo_sF2QVPYAHOp4wV0YHPCTE4e7dx_QRjItGasLERmUMMazK7up1flKwl0x3JgQTssbUQXxUvBlTb08N-Unz__Olm9rW8vPoyn51flkaqKpc1yI6bFuQgWs5qbltWDaKpoKuZkKqhrGZMcgwpt00voe1Np2QHqgHBu46fFPM9tw-w0nfRrSFudQCn_yZCXGiI2ZnRamGAC8sUM0IJU0NLWzCqtxZzSB-Q9WHPupu6te2N9bt_eQJ9euLdUi_CRjct5bWUCHh3AMTwY7Ip67VLxo4jeBumpCvFsX2ruELp23-kqzBFj1-lq1o0lEt8ParkXmViSCna4eEyjOqde_S9e_TOPfrgHqx78_glD1X3XkHBx73A-SHENfwMcex1hu0Y4hDRIS5p_v8efwD4w9Np</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2748035568</pqid></control><display><type>article</type><title>The SARS-CoV-2 inactivated vaccine enhances the broad neutralization against variants in individuals recovered from COVID-19 up to one year</title><source>Taylor &amp; Francis Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Zhou, Xinrong ; Cheng, Lin ; Wang, Haiyan ; Liao, Xuejiao ; Wang, Miao ; Wei, Lanlan ; Song, Shuo ; Zhou, Bing ; Ma, Zhenghua ; Guo, Huimin ; Ge, Xiangyang ; Ju, Bin ; Zhang, Zheng</creator><creatorcontrib>Zhou, Xinrong ; Cheng, Lin ; Wang, Haiyan ; Liao, Xuejiao ; Wang, Miao ; Wei, Lanlan ; Song, Shuo ; Zhou, Bing ; Ma, Zhenghua ; Guo, Huimin ; Ge, Xiangyang ; Ju, Bin ; Zhang, Zheng</creatorcontrib><identifier>ISSN: 2222-1751</identifier><identifier>EISSN: 2222-1751</identifier><identifier>DOI: 10.1080/22221751.2022.2043728</identifier><identifier>PMID: 35184681</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>Antibodies, Neutralizing ; Antibodies, Viral ; Coronaviruses ; COVID-19 - prevention &amp; control ; COVID-19 Vaccines ; Humans ; Letter ; Neutralization Tests ; SARS-CoV-2 - genetics ; Spike Glycoprotein, Coronavirus - genetics ; Vaccines, Inactivated</subject><ispartof>Emerging microbes &amp; infections, 2022-12, Vol.11 (1), p.753-756</ispartof><rights>2022 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. 2022</rights><rights>2022 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. 2022 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c562t-7a5b3c9a5f493173e912f482ab714568017115345603e8d5a9dcb65ba68a43bb3</citedby><cites>FETCH-LOGICAL-c562t-7a5b3c9a5f493173e912f482ab714568017115345603e8d5a9dcb65ba68a43bb3</cites><orcidid>0000-0001-8066-527X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903755/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2748035568?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27502,27924,27925,37012,37013,38516,43895,44590,53791,53793,59143,59144</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35184681$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhou, Xinrong</creatorcontrib><creatorcontrib>Cheng, Lin</creatorcontrib><creatorcontrib>Wang, Haiyan</creatorcontrib><creatorcontrib>Liao, Xuejiao</creatorcontrib><creatorcontrib>Wang, Miao</creatorcontrib><creatorcontrib>Wei, Lanlan</creatorcontrib><creatorcontrib>Song, Shuo</creatorcontrib><creatorcontrib>Zhou, Bing</creatorcontrib><creatorcontrib>Ma, Zhenghua</creatorcontrib><creatorcontrib>Guo, Huimin</creatorcontrib><creatorcontrib>Ge, Xiangyang</creatorcontrib><creatorcontrib>Ju, Bin</creatorcontrib><creatorcontrib>Zhang, Zheng</creatorcontrib><title>The SARS-CoV-2 inactivated vaccine enhances the broad neutralization against variants in individuals recovered from COVID-19 up to one year</title><title>Emerging microbes &amp; infections</title><addtitle>Emerg Microbes Infect</addtitle><subject>Antibodies, Neutralizing</subject><subject>Antibodies, Viral</subject><subject>Coronaviruses</subject><subject>COVID-19 - prevention &amp; control</subject><subject>COVID-19 Vaccines</subject><subject>Humans</subject><subject>Letter</subject><subject>Neutralization Tests</subject><subject>SARS-CoV-2 - genetics</subject><subject>Spike Glycoprotein, Coronavirus - genetics</subject><subject>Vaccines, Inactivated</subject><issn>2222-1751</issn><issn>2222-1751</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kl1rFDEUhgdRbKn9CUrAG2-mJpOPmbkRy9aPhULB1t6GM5nMbpbZpCaZlfUv-Kc9625L64UhJIeT9zwnCW9RvGb0jNGGvq9wsFqys4pWFS6C11XzrDje5cvdwfNH8VFxmtKK4qipEky8LI64ZI1QDTsuft8sLbk-_3ZdzsJtWRHnwWS3gWx7sgFjnLfE-iV4YxPJqO1igJ54O-UIo_sF2QVPYAHOp4wV0YHPCTE4e7dx_QRjItGasLERmUMMazK7up1flKwl0x3JgQTssbUQXxUvBlTb08N-Unz__Olm9rW8vPoyn51flkaqKpc1yI6bFuQgWs5qbltWDaKpoKuZkKqhrGZMcgwpt00voe1Np2QHqgHBu46fFPM9tw-w0nfRrSFudQCn_yZCXGiI2ZnRamGAC8sUM0IJU0NLWzCqtxZzSB-Q9WHPupu6te2N9bt_eQJ9euLdUi_CRjct5bWUCHh3AMTwY7Ip67VLxo4jeBumpCvFsX2ruELp23-kqzBFj1-lq1o0lEt8ParkXmViSCna4eEyjOqde_S9e_TOPfrgHqx78_glD1X3XkHBx73A-SHENfwMcex1hu0Y4hDRIS5p_v8efwD4w9Np</recordid><startdate>20221231</startdate><enddate>20221231</enddate><creator>Zhou, Xinrong</creator><creator>Cheng, Lin</creator><creator>Wang, Haiyan</creator><creator>Liao, Xuejiao</creator><creator>Wang, Miao</creator><creator>Wei, Lanlan</creator><creator>Song, Shuo</creator><creator>Zhou, Bing</creator><creator>Ma, Zhenghua</creator><creator>Guo, Huimin</creator><creator>Ge, Xiangyang</creator><creator>Ju, Bin</creator><creator>Zhang, Zheng</creator><general>Taylor &amp; Francis</general><general>Taylor &amp; Francis Ltd</general><general>Taylor &amp; Francis Group</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8066-527X</orcidid></search><sort><creationdate>20221231</creationdate><title>The SARS-CoV-2 inactivated vaccine enhances the broad neutralization against variants in individuals recovered from COVID-19 up to one year</title><author>Zhou, Xinrong ; Cheng, Lin ; Wang, Haiyan ; Liao, Xuejiao ; Wang, Miao ; Wei, Lanlan ; Song, Shuo ; Zhou, Bing ; Ma, Zhenghua ; Guo, Huimin ; Ge, Xiangyang ; Ju, Bin ; Zhang, Zheng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c562t-7a5b3c9a5f493173e912f482ab714568017115345603e8d5a9dcb65ba68a43bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies, Neutralizing</topic><topic>Antibodies, Viral</topic><topic>Coronaviruses</topic><topic>COVID-19 - prevention &amp; control</topic><topic>COVID-19 Vaccines</topic><topic>Humans</topic><topic>Letter</topic><topic>Neutralization Tests</topic><topic>SARS-CoV-2 - genetics</topic><topic>Spike Glycoprotein, Coronavirus - genetics</topic><topic>Vaccines, Inactivated</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Xinrong</creatorcontrib><creatorcontrib>Cheng, Lin</creatorcontrib><creatorcontrib>Wang, Haiyan</creatorcontrib><creatorcontrib>Liao, Xuejiao</creatorcontrib><creatorcontrib>Wang, Miao</creatorcontrib><creatorcontrib>Wei, Lanlan</creatorcontrib><creatorcontrib>Song, Shuo</creatorcontrib><creatorcontrib>Zhou, Bing</creatorcontrib><creatorcontrib>Ma, Zhenghua</creatorcontrib><creatorcontrib>Guo, Huimin</creatorcontrib><creatorcontrib>Ge, Xiangyang</creatorcontrib><creatorcontrib>Ju, Bin</creatorcontrib><creatorcontrib>Zhang, Zheng</creatorcontrib><collection>Taylor &amp; Francis Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Emerging microbes &amp; infections</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Xinrong</au><au>Cheng, Lin</au><au>Wang, Haiyan</au><au>Liao, Xuejiao</au><au>Wang, Miao</au><au>Wei, Lanlan</au><au>Song, Shuo</au><au>Zhou, Bing</au><au>Ma, Zhenghua</au><au>Guo, Huimin</au><au>Ge, Xiangyang</au><au>Ju, Bin</au><au>Zhang, Zheng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The SARS-CoV-2 inactivated vaccine enhances the broad neutralization against variants in individuals recovered from COVID-19 up to one year</atitle><jtitle>Emerging microbes &amp; infections</jtitle><addtitle>Emerg Microbes Infect</addtitle><date>2022-12-31</date><risdate>2022</risdate><volume>11</volume><issue>1</issue><spage>753</spage><epage>756</epage><pages>753-756</pages><issn>2222-1751</issn><eissn>2222-1751</eissn><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>35184681</pmid><doi>10.1080/22221751.2022.2043728</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-8066-527X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2222-1751
ispartof Emerging microbes & infections, 2022-12, Vol.11 (1), p.753-756
issn 2222-1751
2222-1751
language eng
recordid cdi_pubmed_primary_35184681
source Taylor & Francis Open Access; Publicly Available Content Database; PubMed Central; Coronavirus Research Database
subjects Antibodies, Neutralizing
Antibodies, Viral
Coronaviruses
COVID-19 - prevention & control
COVID-19 Vaccines
Humans
Letter
Neutralization Tests
SARS-CoV-2 - genetics
Spike Glycoprotein, Coronavirus - genetics
Vaccines, Inactivated
title The SARS-CoV-2 inactivated vaccine enhances the broad neutralization against variants in individuals recovered from COVID-19 up to one year
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T10%3A03%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20SARS-CoV-2%20inactivated%20vaccine%20enhances%20the%20broad%20neutralization%20against%20variants%20in%20individuals%20recovered%20from%20COVID-19%20up%20to%20one%20year&rft.jtitle=Emerging%20microbes%20&%20infections&rft.au=Zhou,%20Xinrong&rft.date=2022-12-31&rft.volume=11&rft.issue=1&rft.spage=753&rft.epage=756&rft.pages=753-756&rft.issn=2222-1751&rft.eissn=2222-1751&rft_id=info:doi/10.1080/22221751.2022.2043728&rft_dat=%3Cproquest_pubme%3E2748035568%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c562t-7a5b3c9a5f493173e912f482ab714568017115345603e8d5a9dcb65ba68a43bb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2748035568&rft_id=info:pmid/35184681&rfr_iscdi=true